Japanese phase II study of Avastin plus paclitaxel and cisplatin in patients with advanced or recurrent cervical cancer

Trial Profile

Japanese phase II study of Avastin plus paclitaxel and cisplatin in patients with advanced or recurrent cervical cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Cervical cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 23 May 2016 According to Chugai media release, on September 14, 2015, Avastin was granted orphan drug desination advanced or recurrent cervical cancer.
    • 18 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top